What is IRESSA (Gefinitib)?
IRESSA is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.
For treatment related information, please consult your treating Physician..
250mg (30 tabs)
Storage and handling:
Store at 20° to 25° C, excursions permitted to 15° to 30° C
How do we source the Drug?
SSPWL sources its drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.
Company that Manufactures/ Markets:
Assistance Cell in India:
For ONCOLOGY DRUG: IRESSA (gefitinib)price.
Call: +91 07738100125 / +91 07738151650 or